BLAU3 Stock Overview
A pharmaceutical company provides high-complpexity drugs in Brazil, Argentina, Chile, Colombia, Uruguay, Ecuador, Peru, and the United States.
Snowflake Score | |
---|---|
Valuation | 3/6 |
Future Growth | 3/6 |
Past Performance | 2/6 |
Financial Health | 6/6 |
Dividends | 2/6 |
Blau Farmacêutica S.A. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | R$14.79 |
52 Week High | R$17.73 |
52 Week Low | R$9.20 |
Beta | 0.40 |
11 Month Change | 12.30% |
3 Month Change | 26.09% |
1 Year Change | -8.25% |
33 Year Change | -55.59% |
5 Year Change | n/a |
Change since IPO | -64.01% |
Recent News & Updates
Recent updates
Blau Farmacêutica S.A.'s (BVMF:BLAU3) 31% Price Boost Is Out Of Tune With Earnings
Aug 29Is Blau Farmacêutica (BVMF:BLAU3) A Risky Investment?
Jun 28Lacklustre Performance Is Driving Blau Farmacêutica S.A.'s (BVMF:BLAU3) 26% Price Drop
Feb 01What Does The Future Hold For Blau Farmacêutica S.A. (BVMF:BLAU3)? These Analysts Have Been Cutting Their Estimates
May 14Blau Farmacêutica S.A. Just Missed EPS By 18%: Here's What Analysts Think Will Happen Next
Feb 24Getting In Cheap On Blau Farmacêutica S.A. (BVMF:BLAU3) Is Unlikely
Oct 14Robust Earnings May Not Tell The Whole Story For Blau Farmacêutica (BVMF:BLAU3)
Aug 17Shareholder Returns
BLAU3 | BR Biotechs | BR Market | |
---|---|---|---|
7D | 12.9% | 0.9% | 0.7% |
1Y | -8.3% | 21.6% | 9.6% |
Return vs Industry: BLAU3 underperformed the BR Biotechs industry which returned 21.6% over the past year.
Return vs Market: BLAU3 underperformed the BR Market which returned 9.6% over the past year.
Price Volatility
BLAU3 volatility | |
---|---|
BLAU3 Average Weekly Movement | 7.3% |
Biotechs Industry Average Movement | 9.2% |
Market Average Movement | 4.4% |
10% most volatile stocks in BR Market | 9.1% |
10% least volatile stocks in BR Market | 2.2% |
Stable Share Price: BLAU3's share price has been volatile over the past 3 months compared to the BR market.
Volatility Over Time: BLAU3's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of BR stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1987 | 1,900 | Marcelo Hahn | www.blau.com |
Blau Farmacêutica S.A., a pharmaceutical company provides high-complpexity drugs in Brazil, Argentina, Chile, Colombia, Uruguay, Ecuador, Peru, and the United States. Its medications cover various segments, such as immunology, hematology, oncology, nephrology, infectious diseases, anesthesiology, and others. The company provides uterine stimulator; anesthetics; feminine health care; oncological products; antivirals and antiretrovirals; acid pump inhibitor; antithrombotic; antirheumatic; antibiotics; biopharmaceuticals; essential hospital products; biosimilars; hemoderivatives; and thrombolytics.
Blau Farmacêutica S.A. Fundamentals Summary
BLAU3 fundamental statistics | |
---|---|
Market cap | R$2.63b |
Earnings (TTM) | R$217.68m |
Revenue (TTM) | R$1.57b |
12.1x
P/E Ratio1.7x
P/S RatioIs BLAU3 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
BLAU3 income statement (TTM) | |
---|---|
Revenue | R$1.57b |
Cost of Revenue | R$1.05b |
Gross Profit | R$520.57m |
Other Expenses | R$302.89m |
Earnings | R$217.68m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Nov 05, 2024
Earnings per share (EPS) | 1.23 |
Gross Margin | 33.05% |
Net Profit Margin | 13.82% |
Debt/Equity Ratio | 25.5% |
How did BLAU3 perform over the long term?
See historical performance and comparisonDividends
5.1%
Current Dividend Yield10%
Payout RatioDoes BLAU3 pay a reliable dividends?
See BLAU3 dividend history and benchmarksBlau Farmacêutica dividend dates | |
---|---|
Ex Dividend Date | Apr 30 2024 |
Dividend Pay Date | Dec 31 2024 |
Days until Ex dividend | 173 days |
Days until Dividend pay date | 72 days |
Does BLAU3 pay a reliable dividends?
See BLAU3 dividend history and benchmarks